Management of Metastatic Gastric Cancer

OBERMANNOVÁ, Radka and Florian LORDICK. Management of Metastatic Gastric Cancer. Hematology-Oncology Clinics of North America. PHILADELPHIA: W B Sauders Co-Elsevier Inc., 2017, vol. 31, No 3, p. "469"-"+", 16 pp. ISSN 0889-8588. Available from: https://dx.doi.org/10.1016/j.hoc.2017.01.006.

Basic information

Original name

Management of Metastatic Gastric Cancer

Authors

OBERMANNOVÁ, Radka (203 Czech Republic, guarantor, belonging to the institution) and Florian LORDICK (276 Germany)

Edition

Hematology-Oncology Clinics of North America, PHILADELPHIA, W B Sauders Co-Elsevier Inc. 2017, 0889-8588

---

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 3.098

RIV identification code

RIV/00216224:14110/17:00100258

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.hoc.2017.01.006

UT WoS

000403381800007

Keywords in English

Gastric cancer; Metastases; Chemotherapy; Radiotherapy; Surgery; Doublet; Triplet; Sequence

Tags

EL OK

Tags

International impact, Reviewed

---

Abstract

V originále

Metastatic gastric cancer is an incurable disease. Systemic chemotherapy prolongs survival, improves symptom control, and helps maintain a better quality of life of patients with metastatic gastric cancer. HER2 testing of the primary tumor and/or the metastases is warranted before initiation of first line treatment. This review article outlines the indication and clinical data of medical treatment of advanced gastric cancer and highlights aspects of quality of life.